Back to Startups

SignalPath by Verily

SignalPath from Verily is a state-of-the-art clinical trial management system (CTMS) for research sites that digitizes study protocols and eliminates siloed manual processes to enable high-quality research and maximize research revenue.

About

SignalPath is the premier clinical trial technology partner for research sites and sponsors, focused on improving the ease and efficiency of trial execution and management. Supporting over 2,500 trials across 250 sites and 3,000 active users, SignalPath is the industry standard that addresses key pain points in the conduct of trials. Their data science and protocol experts unpack protocol complexities and convert them into automated study workflows (including schedule of events, inclusion/exclusion criteria, randomization and other critical protocol-defined events). Pre- and post-award financial tools enable a single source of truth across all clinical research activities. In addition, the SignalPath CTMS integrates with leading eClinical technologies so sites can maximize their existing trial ecosystem.

Core Features

  • Manage all study visits and activities in one place
  • Track your site’s performance
  • Real-time study metrics
  • Streamline your pre-award process
  • Enhance site profitability & optimize research cash flows
  • Connected ecosystem
  • Quickly reference key visit activities for each protocol and participant, ensuring compliance and safety for every patient and study.
  • The SignalPath CTMS integrates with leading eClinical technologies so sites can maximize their existing trial ecosystem.

Supercharger Scorecard
9.7
Market Size
12.51% CAGR, $2.75B by 2027
Location
San Francisco, CA
Total Funding
Acquired by Verily
Web Traffic
#404,926 Global Rank
109.2K Total Visits
2.23 Pages Per Visit
Product Offerings
SignalPath CTMS
SEC FilingEmail Founder

BAcked By

No items found.

Product Overview

No items found.

Latest News & Traction

Inquire Today!

Start your 14-day free trial

Supercharger evaluates venture outcomes so you don't have to. This offer may not be available if you leave this web page and return later.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Free 14-day Trial

Autonomous ETL for Investors and FIs